Synnovation Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Synnovation Therapeutics's estimated annual revenue is currently $13.7M per year.
- Synnovation Therapeutics's estimated revenue per employee is $244,071
- Synnovation Therapeutics's total funding is $139M.
Employee Data
- Synnovation Therapeutics has 56 Employees.
- Synnovation Therapeutics grew their employee count by 37% last year.
Synnovation Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
2 | Co-Founder & SVP Drug Discovery | Reveal Email/Phone |
3 | SVP Business Development | Reveal Email/Phone |
4 | SVP, Head Biology | Reveal Email/Phone |
5 | SVP Head Clinical Development | Reveal Email/Phone |
6 | Executive Director, Head Process Chemistry, CMC | Reveal Email/Phone |
7 | Executive Director, Clinical Development | Reveal Email/Phone |
8 | Associate Director | Reveal Email/Phone |
9 | Senior Director | Reveal Email/Phone |
10 | Director, Translational Science | Reveal Email/Phone |
Synnovation Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $44.4M | 221 | 31% | N/A | N/A |
#2 | $10.3M | 51 | -27% | N/A | N/A |
#3 | $83.2M | 414 | 6% | N/A | N/A |
#4 | $59.9M | 298 | -9% | N/A | N/A |
#5 | $9.4M | 47 | 42% | N/A | N/A |
#6 | $136.3M | 678 | -8% | N/A | N/A |
#7 | $29.9M | 149 | 13% | N/A | N/A |
#8 | $0.7M | 7 | 0% | N/A | N/A |
#9 | $3M | 15 | 50% | N/A | N/A |
#10 | $9.6M | 48 | 7% | N/A | N/A |
What Is Synnovation Therapeutics?
Synnovation Therapeutics is a precision medicine company developing small molecule therapies optimized to achieve best-in-class pharmacology against highly validated disease targets.\n\nWe are dedicated to the discovery and development of best-in-class therapeutics that can improve the lives of people living with cancer. Leveraging deep expertise in cancer biology and a world class medicinal chemistry team, we are building a diverse pipeline of novel small molecule targeted therapies. Our mission is to efficiently advance these agents into clinical trials with the goal of transforming cancer care through patient-focused precision medicine.
keywords:N/A
$139M
Total Funding
56
Number of Employees
$13.7M
Revenue (est)
37%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Wilmington
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.6M | 56 | -3% | N/A |
#2 | $8.2M | 56 | 51% | $10M |
#3 | $10.6M | 56 | 2% | N/A |
#4 | $19.3M | 56 | 24% | N/A |
#5 | $12.8M | 56 | 22% | N/A |